Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN studIeS for TreatMent of Acute Myocardial Infarction: MECHANISM-AMI

Trial Profile

Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN studIeS for TreatMent of Acute Myocardial Infarction: MECHANISM-AMI

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Nov 2016

At a glance

  • Drugs Everolimus (Primary)
  • Indications Coronary artery restenosis; Myocardial infarction; Stent thrombosis
  • Focus Therapeutic Use
  • Acronyms MECHANISM-AMI
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 26 May 2016 Bare metal stent has been removed from the study hence, study title, study design (randomized to non randomised and interventional to observational), inclusion criteria and treatment (Vascular responses are evaluated at 2 weeks or 3 months OCT follow-up) changed.
    • 26 May 2016 Planned number of patients changed from 180 to 100.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top